Published in Clin Chest Med on March 01, 2002
Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirus. J Gene Med (2010) 0.84
Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma. Cancer Gene Ther (2011) 0.78
Conference report--gene therapy and lung cancer--no time to wait. MedGenMed (2004) 0.75
Tumors of the mediastinum. Chest (2005) 5.12
The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol (2011) 2.79
A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci (2003) 2.34
An approach to interventional pulmonary fellowship training. Chest (2010) 2.13
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease. J Thorac Oncol (2015) 1.92
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Clin Cancer Res (2011) 1.78
PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress. Am J Physiol Lung Cell Mol Physiol (2003) 1.74
Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration (2005) 1.70
A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg (2003) 1.66
The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol (2014) 1.51
Transbronchial needle injection: a systematic review of a new diagnostic and therapeutic paradigm. Respiration (2006) 1.51
Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol (2013) 1.45
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer (2007) 1.36
Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer. Int J Cancer (2007) 1.28
Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung. Cancer Res (2005) 1.26
Endobronchial valve treatment for prolonged air leaks of the lung: a case series. Ann Thorac Surg (2011) 1.22
A multicenter trial of an intrabronchial valve for treatment of severe emphysema. J Thorac Cardiovasc Surg (2006) 1.22
Advances in diagnostic bronchoscopy. Am J Respir Crit Care Med (2010) 1.18
Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy. Hum Gene Ther (2010) 1.14
Gene expression profiling of malignant mesothelioma. Clin Cancer Res (2003) 1.10
Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study. Cancer Immunol Immunother (2007) 1.08
Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma. J Thorac Cardiovasc Surg (2004) 1.05
Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (Removab) (anti-EpCAM x Anti-CD3): results of a phase 1/2 study. J Immunother (2009) 1.05
Malignant pleural effusions: management options with consideration of coding, billing, and a decision approach. Chest (2007) 1.03
Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment. Am J Respir Crit Care Med (2009) 1.02
Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol (2007) 1.02
Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma. Cancer Biol Ther (2005) 1.00
The prognostic impact of blood group-related antigen Lewis Y and the ABH blood groups in resected non-small cell lung cancer. Tumour Biol (2008) 1.00
Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature. J Pharmacol Exp Ther (2002) 1.00
Photodynamic therapy for the treatment of non-small cell lung cancer. J Thorac Dis (2012) 0.99
Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies. Clin Chest Med (2013) 0.98
Streptavidin-biotin crosslinking of therapeutic enzymes with carrier antibodies: nanoconjugates for protection against endothelial oxidative stress. Methods Mol Biol (2004) 0.98
Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissue. Anticancer Res (2009) 0.96
Non-invasive ventilation in immunosuppressed patients with pneumonia and extrapulmonary sepsis. Respir Med (2012) 0.94
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer. J Thorac Oncol (2014) 0.94
Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers. Am J Respir Cell Mol Biol (2004) 0.93
PECAM-directed immunotargeting of catalase: specific, rapid and transient protection against hydrogen peroxide. Free Radic Biol Med (2003) 0.90
Cytokine gene therapy for malignant pleural mesothelioma. J Thorac Oncol (2007) 0.89
c-kit expression in adenocarcinomas of the lung. Tumour Biol (2005) 0.87
Pilot randomized study comparing two techniques of airway anaesthesia during curvilinear probe endobronchial ultrasound bronchoscopy (CP-EBUS). Respirology (2011) 0.87
An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cell. Cancer Res (2002) 0.86
Targeted endothelial delivery of nanosized catalase immunoconjugates protects lung grafts donated after cardiac death. Transplantation (2011) 0.86
Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy. Mol Ther (2002) 0.85
Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey. J Cell Biochem (2002) 0.84
Gene therapy for lung neoplasms. Clin Chest Med (2011) 0.84
Functional and clinical characterization of the putative tumor suppressor WWOX in non-small cell lung cancer. J Thorac Oncol (2011) 0.84
A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes. Cancer Res (2009) 0.83
The European initiative for quality management in lung cancer care. Eur Respir J (2014) 0.83
Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013. Hum Gene Ther (2014) 0.82
Novel intrapleural therapies for malignant diseases. Respiration (2012) 0.82
Endobronchial ultrasound. When to venture into the vasculature. Ann Am Thorac Soc (2013) 0.82
Diagnosis of idiopathic tracheal stenosis and treatment with papillotome electrocautery and balloon bronchoplasty. Respir Care (2011) 0.82
Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancer. PLoS One (2012) 0.81
Blockade of TNF-alpha decreases both inflammation and efficacy of intrapulmonary Ad.IFNbeta immunotherapy in an orthotopic model of bronchogenic lung cancer. Mol Ther (2006) 0.80
Airway complications following lung transplantation. Clin Chest Med (2011) 0.80
Endoscopic lung volume reduction. An American perspective. Ann Am Thorac Soc (2013) 0.80
Suramin inhibits the growth of malignant mesothelioma in vitro, and in vivo, in murine flank and intraperitoneal models. Lung Cancer (2003) 0.80
DNA methyltransferase inhibition reverses epigenetically embedded phenotypes in lung cancer preferentially affecting polycomb target genes. Clin Cancer Res (2013) 0.80
TA-MUC1 epitope in non-small cell lung cancer. Lung Cancer (2008) 0.80
High-dose-rate (HDR) brachytherapy for the treatment of benign obstructive endobronchial granulation tissue. Int J Radiat Oncol Biol Phys (2006) 0.79
Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. Transpl Int (2010) 0.79
TNFerade to the rescue? Guidelines for evaluating phase I cancer gene transfer trials. J Clin Oncol (2004) 0.78
Intracavitary therapeutics for pleural malignancies. Clin Chest Med (2013) 0.78
Bronchial sleeve resection for posttransplant stricture. Ann Thorac Surg (2003) 0.78
Bringing comfort to endobronchial ultrasound bronchoscopy. Am J Respir Crit Care Med (2015) 0.77
High yield of bronchoscopic transparenchymal nodule access real-time image-guided sampling in a novel model of small pulmonary nodules in canines. Chest (2015) 0.77
Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome. J Thorac Cardiovasc Surg (2002) 0.76
EUS staging of primary lung carcinoma: are we ready for it? Gastrointest Endosc (2004) 0.75
Malignant pleural mesothelioma: not immune to the effects of novel therapeutic interventions? Am J Respir Crit Care Med (2010) 0.75
Secondary carina Y-stent placement for post-lung-transplant bronchial stenosis. J Bronchology Interv Pulmonol (2012) 0.75
Endotracheal spindle cell lipoma presenting as a chronic cough. J Bronchology Interv Pulmonol (2009) 0.75
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer. PLoS One (2017) 0.75
[Current Individualized Therapy Strategies for Metastasized Lung Cancer]. Dtsch Med Wochenschr (2017) 0.75
Endobronchial ultrasound-guided sheath placement to guide transbronchial biopsy of mediastinal lymphadenopathy and lung mass: a new technique. J Bronchology Interv Pulmonol (2015) 0.75
Short-term Placement of Multiple Self-expandable Metallic Stents for the Treatment of Bilateral Bronchial Dehiscences Complicating Lung Transplantation. J Bronchology Interv Pulmonol (2009) 0.75
Stent-mediated gene delivery for site-specific transgene administration to the airway epithelium and management of tracheobronchial tumors. Respiration (2014) 0.75
Endobronchial gene therapy. Semin Respir Crit Care Med (2004) 0.75
The revolution is here...long live the revolution. J Bronchology Interv Pulmonol (2012) 0.75